Thymosin Alpha-1 vs Thymosin Beta-4

Immune / Healing

Both thymosin peptides originate from the thymus gland but serve different primary roles. Thymosin Alpha-1 (Tα1) is an immune modulator that enhances T-cell function, boosts antibody production, and fights chronic infections — it's approved as Zadaxin in 35+ countries. Thymosin Beta-4 (Tβ4) is a tissue repair peptide that promotes cell migration, angiogenesis, and wound healing. They are complementary: Tα1 energizes the immune system while Tβ4 repairs the damage.

moderate Search Demand

Side-by-Side Comparison

Aspect	Thymosin Alpha-1	Thymosin Beta-4
dosing	1.6 mg SubQ 2x weekly (standard immune protocol)	750 mcg - 2 mg SubQ daily or several times weekly
best for	Chronic infections, hepatitis B/C, immune suppression, cancer adjunct therapy, vaccine enhancement	Tissue repair, wound healing, cardiac recovery, muscle/tendon injuries, anti-inflammation
stacking	Synergistic stack — Tα1 prevents excessive immune activation while Tβ4 reduces inflammatory damage. Together: immune defense + tissue repair. Used in protocols for chronic illness recovery.	—
mechanism	28-amino-acid immune modulator — enhances T-cell maturation, dendritic cell function, and NK cell activity	43-amino-acid repair peptide — promotes actin polymerization, cell migration, angiogenesis, and anti-inflammation
fda status	Not FDA-approved but approved in 35+ countries as Zadaxin	Not FDA-approved; research peptide
side effects	Generally well-tolerated; mild injection site reactions, rare flu-like symptoms	Minimal — occasional head rush, fatigue during loading
primary system	Adaptive immune system — T-cells, dendritic cells, antibodies	Tissue repair system — cell migration, blood vessel formation, inflammation resolution

Verdict

Thymosin Alpha-1 for immune support and infection fighting. Thymosin Beta-4 for tissue repair and healing. They address different systems and stack exceptionally well for comprehensive recovery.